Adverse events and responses in patients with recurrent ovarian cancer undergoing early-phase immune checkpoint inhibitor clinical trials
Gynecologic Oncology（2018）
摘要
Objective: To describe the clinical outcomes associated with the use of checkpoint inhibitor immune therapy in recurrent ovarian malignancy.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要